home / stock / mrkr / mrkr short
Short Information | Marker Therapeutics Inc. (NASDAQ:MRKR)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 243,305 |
Total Actual Volume | 728,078 |
Short Trends | |
---|---|
Cover Days | 15 |
Short Days | 0 |
No Change Days | 5 |
Averages | |
---|---|
Average Short Volume | 12,165 |
Average Short Percentage | 25.30% |
Is there a MRKR Short Squeeze or Breakout about to happen?
See the MRKR Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-03-2024 | $5.3 | $5.19 | $5.3 | $5.09 | 6,378 | 1,426 | 22.36% |
07-02-2024 | $5.3 | $5.24 | $5.48 | $5.24 | 25,482 | 9,616 | 37.74% |
07-01-2024 | $5.36 | $5.39 | $5.68 | $5.2101 | 31,400 | 7,773 | 24.75% |
06-28-2024 | $4.74 | $5.43 | $5.4601 | $4.44 | 77,956 | 32,662 | 41.9% |
06-27-2024 | $4.68 | $4.83 | $4.83 | $4.47 | 22,101 | 7,189 | 32.53% |
06-26-2024 | $4.72 | $4.74 | $4.88 | $4.576 | 16,694 | 3,240 | 19.41% |
06-25-2024 | $4.7 | $4.64 | $4.74 | $4.58 | 11,244 | 2,453 | 21.82% |
06-24-2024 | $4.26 | $4.71 | $4.75 | $4.1623 | 39,444 | 16,056 | 40.71% |
06-21-2024 | $4.41 | $4.32 | $4.445 | $4.02 | 15,170 | 3,311 | 21.83% |
06-20-2024 | $4.73 | $4.49 | $4.73 | $4.46 | 44,758 | 1,254 | 2.8% |
06-18-2024 | $4.92 | $4.62 | $4.95 | $4.55 | 76,337 | 22,648 | 29.67% |
06-17-2024 | $4.24 | $4.78 | $4.78 | $4.11 | 161,791 | 78,424 | 48.47% |
06-14-2024 | $4.02 | $4.1647 | $4.2399 | $4.0199 | 3,146 | 649 | 20.63% |
06-13-2024 | $3.93 | $4.02 | $4.22 | $3.93 | 16,772 | 622 | 3.71% |
06-12-2024 | $3.5 | $4 | $4.25 | $3.5 | 25,476 | 3,107 | 12.2% |
06-11-2024 | $3.59 | $3.86 | $4.09 | $3.42 | 71,928 | 34,377 | 47.79% |
06-10-2024 | $3.54 | $3.47 | $3.6 | $3.3835 | 47,053 | 12,779 | 27.16% |
06-07-2024 | $3.45 | $3.47 | $3.5999 | $3.3574 | 10,312 | 2,747 | 26.64% |
06-06-2024 | $3.62 | $3.33 | $3.6943 | $3.33 | 13,420 | 1,780 | 13.26% |
06-05-2024 | $3.55 | $3.65 | $3.75 | $3.55 | 11,216 | 1,192 | 10.63% |
News, Short Squeeze, Breakout and More Instantly...
Marker Therapeutics Inc. Company Name:
MRKR Stock Symbol:
NASDAQ Market:
Marker Therapeutics Inc. Website:
Preliminary safety and efficacy with sustained objective responses observed in patients with lymphoma treated with MT-601 in Phase 1 APOLLO study Study participant with Non-Hodgkin’s Lymphoma who relapsed within 90 days of anti-CD19 CAR T cell therapy remains in complete response...
Preliminary data from study in patients with lymphoma enrolled at City of Hope National Medical Center was presented at the 11 th Global Summit on Hematologic Malignancies in Whistler, BC, Canada Study participants tolerated initial dose level well and demonstrated durab...